NCT04669860 is a clinical trial in Calcium Oxalate Urolithiasis, sponsored by University of Miami.

Who is sponsoring NCT04669860?

NCT04669860 is sponsored by University of Miami.

What condition does NCT04669860 study?

NCT04669860 studies Calcium Oxalate Urolithiasis, Renal Cell Carcinoma.

Is NCT04669860 still recruiting?

NCT04669860 is currently suspended. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT04669860

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma

Suspended Last updated 8 September 2025

What this trial tests

trial in Calcium Oxalate Urolithiasis in 90 participants. Suspended.

Timeline

24 February 2021

Primary endpoint
1 September 2027

1 January 2028

Quick facts

Lead sponsor	University of Miami
Status	Suspended
Study type	OBSERVATIONAL
Enrollment	90
Start date	24 February 2021
Primary completion	1 September 2027
Estimated completion	1 January 2028
Sites	1 location across United States

Conditions studied

Calcium Oxalate Urolithiasis — all drugs for Calcium Oxalate Urolithiasis →
Renal Cell Carcinoma — all drugs for Renal Cell Carcinoma →

Sponsor

University of Miami

Who can join

18 and older, any sex, with Calcium Oxalate Urolithiasis or Renal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to identify bacterial and fungal microbiome associated with calcium oxalate (CO) urolithiasis and renal cell carcinoma (RCC).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Tumor microbiome - an integral part of the tumor microenvironment.
Ciernikova S, Sevcikova A, Stevurkova V, Mego M. · · 2022 · cited 56× · PMID 36505811 · DOI 10.3389/fonc.2022.1063100
The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers.
Pfail J, Drobner J, Doppalapudi K, Saraiya B, et al · · 2024 · cited 6× · PMID 38846356 · DOI 10.33696/cancerimmunol.6.078

Verify or expand the search:

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04669860 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04669860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing